Moomoo AI 已提取核心信息
Safety Shot, Inc. has filed an amendment to its Quarterly Report for the period ended September 30, 2023, reflecting a reclassification of financial statements due to the separation of SRM Ltd from the company. The separation, which included an exchange of shares and an IPO for SRM, resulted in Safety Shot owning 4,500,000 shares of SRM's outstanding common stock. Consequently, SRM is no longer consolidated and is accounted for using the equity method. Financial performance for the three and nine months ended September 30, 2023, shows a net loss of $7,738,301 and $9,406,066 respectively, with a basic loss per share of $0.26 and $0.34. The company's cash position improved to $4,387,797 from $1,477,552 at the end of the previous year. Safety Shot, Inc. launched the Safety Shot product in...Show More
Safety Shot, Inc. has filed an amendment to its Quarterly Report for the period ended September 30, 2023, reflecting a reclassification of financial statements due to the separation of SRM Ltd from the company. The separation, which included an exchange of shares and an IPO for SRM, resulted in Safety Shot owning 4,500,000 shares of SRM's outstanding common stock. Consequently, SRM is no longer consolidated and is accounted for using the equity method. Financial performance for the three and nine months ended September 30, 2023, shows a net loss of $7,738,301 and $9,406,066 respectively, with a basic loss per share of $0.26 and $0.34. The company's cash position improved to $4,387,797 from $1,477,552 at the end of the previous year. Safety Shot, Inc. launched the Safety Shot product in December 2023, expanding its product pipeline which includes treatments for various health and wellness concerns. The company generates revenue through sales and licensing royalties, with products available through retailers and e-commerce platforms. Despite the net losses, the company has a positive working capital and continues to invest in research and development for its product lines. The report raises concerns about the company's ability to continue as a going concern, with accumulated deficits of $60,003,740 as of September 30, 2023.
Safety Shot, Inc.已提交了截至2023年9月30日的季度报告的修正案，反映了由于SRM Ltd脱离公司而对财务报表进行了重新分类。分离包括股票交换和SRM的首次公开募股，导致Safety Shot拥有SRM已发行普通股的450万股。因此，SRM不再合并，而是使用权益法进行核算。截至2023年9月30日的三个月和九个月的财务业绩分别显示净亏损7,738,301美元和9,406,066美元，基本每股亏损为0.26美元和0.34美元。该公司的现金状况从去年年底的1,477,552美元改善至4,387,797美元。Safety Shot, Inc. 于 2023 年 12 月推出了 S...展开全部
Safety Shot, Inc.已提交了截至2023年9月30日的季度报告的修正案，反映了由于SRM Ltd脱离公司而对财务报表进行了重新分类。分离包括股票交换和SRM的首次公开募股，导致Safety Shot拥有SRM已发行普通股的450万股。因此，SRM不再合并，而是使用权益法进行核算。截至2023年9月30日的三个月和九个月的财务业绩分别显示净亏损7,738,301美元和9,406,066美元，基本每股亏损为0.26美元和0.34美元。该公司的现金状况从去年年底的1,477,552美元改善至4,387,797美元。Safety Shot, Inc. 于 2023 年 12 月推出了 Safety Shot 产品，扩大了其产品线，其中包括针对各种健康和保健问题的治疗。该公司通过销售和许可使用费创造收入，产品可通过零售商和电子商务平台购买。尽管出现净亏损，但该公司拥有正的营运资金，并将继续投资于其产品线的研发。该报告引发了人们对该公司继续经营能力的担忧，截至2023年9月30日，累计赤字为60,003,740美元。
有用
没用
